News for Healthier Living

Mayo Clinic Research Supports Targeted Therapy to Manage Kidney Complications, Potentially Enabling Continuation of Lifesaving Immunotherapy

Immune checkpoint inhibitors (ICIs) have transformed cancer treatment but can cause kidney-related immune complications in some patients, sometimes requiring therapy to be paused or stopped. A study led by Dr. Sandra Herrmann at Mayo Clinic sheds light on how this inflammation develops and offers early evidence for a targeted approach to better manage--and potentially prevent--these side effects.

April 22, 2026


May 1 2026

April 30 2026

April 29 2026

April 28 2026

April 27 2026

April 26 2026

April 25 2026

April 24 2026

April 23 2026

April 22 2026

April 21 2026

April 20 2026

April 19 2026

April 18 2026